Exercício físico aeróbico ou ventilação não invasiva, qual mais eficaz contra o declínio da função pulmonar de pacientes com fibrose cística? Uma revisão sistemática

Abstract

BACKGROUND: Cystic Fibrosis (CF) or mucoviscidosis is a genetic disease caused by changes in the long arm of chromosome 7 that causes defects in the production of CFTR (Cystic Fibrosis Transmembrane Transmittance Conductance). pulmonary. Physical therapy makes it necessary in this scenario to use therapies such as aerobic exercise and NIV. OBJECTIVE: To conduct a systematic review to determine which therapeutic therapy between NIV and aerobic exercise is most effective in reducing the deterioration of lung function in patients with cystic fibrosis. DATA SOURCES: A literature search using the following databases: Scopus, MEDLINE-PubMed, Web of Science, PEDRO, and Science Direct. STUDY SELECTION: Clinical trials of a cystic fibrosis patient who used NIV or performed aerobic exercise to promote positive changes in lung function. SELECTION CRITERIA: Randomized controlled trials of patients with chemical fibrosis who use NIV or perform aerobic exercise to promote positive changes in lung function. RESULTS: A total of 2,701 studies were used, with only 8 included in the inclusion of the present study, with 1 added in the search manual, ending with 9 studies. Regarding the therapies used, there was a numerical superiority in relation to the studies that used aerobic exercises (6 studies), while those that used the NIV (3 studies) were smaller. CONCLUSION: Aerobic exercise protocols demonstrated better results in pulmonary function in CF patients than studies using NIV as a treatment.